NeuroNEXT

MGNet, an NIH-funded Rare Diseases Clinical Research Consortium (RDCRC) in partnership with the Myasthenia Gravis Foundation of America and Concur MG, is seeking proposals that address the clinical research field in Myasthenia Gravis. Please see the attached notice for more information regarding this opportunity.

The slide presentation from the 2019 NeuroNEXT Annual Meeting in Pittsburgh, PA October 28-29 are now available on the NeuroNEXT private website. They can be accessed under Network Materials > Annual Meetings. Thanks to everyone for a successful meeting!

We are very excited to announce the first ever NINDS podcast for trainees! The vision for the podcast is threefold: provide an introduction to the grant cycle with an emphasis on what is unique about the way NINDS does things, address some commonly-asked questions; and personal advice from staff across the NINDS including Senior Leadership,…

The 2019 Clinical Trials Methodology Course was held in Iowa City in July. See below for an informational video from the University of Iowa on how the course helps investigators design large scale neurological studies.

The AAN is collaborating with the Medical University of South Carolina (MUSC) to offer The TRANSCENDS (Training in Research for Academic Neurologists to Sustain Careers and Enhance the Numbers of Diverse Scholars) Scholars program. This program is funded by a NINDS R25. The TRANSCENDS program is designed to train promising early-career neurologists to conduct high-quality…

NeuroNEXT was well-represented at the 40th Annual Meeting of the Society for Clinical Trials (SCT) this week. The meeting – hosted in New Orleans, LA, May 19-22, 2019 – featured two invited sessions by NeuroNEXT personnel: One contributed session also featured NeuroNEXT: And one poster session: Thanks to everyone for for promoting the excellent work of the…

NIH is soliciting for Pain Research Centers to join a clinical trial network.  NIH has mounted a major effort to improve pain management as a part of its response to the opioid crisis in America.  One cornerstone of that effort is an phase 2 clinical trial network to test new, non-addictive pain therapies in well-phenotyped…

Dr. Robert Fox, PI of the NN102 SPRINT-MS study was the 2019 recipient of Cleveland Clinic’s Sones Innovation Award for the advances in progressive multiple sclerosis made by the NN102 study. This award recognizes advances in innovation in the service of improved patient care. Congratulations to Dr. Fox and the NN102 SPRINT-MS team!

The dataset from the NN102 SPRINT-MS project is now publicly available from the NINDS repository. Researchers interested in accessing this data should complete the NINDS Data Request Form and send it via email to the NINDS Clinical Research Liaison at: CRLiaison@ninds.nih.gov. 

Applications for the NINDS-funded Clinical Trials Methodology Course (CTMC) 2019 are due February 28, 2019 at midnight. Application forms and additional details are available at http://neurotrials.training. Early applications may be considered for early acceptance.